无创通气在急性高碳酸血症性呼吸衰竭中的获益
本文综述无创通气(NIV)在急性高碳酸血症性呼吸衰竭(AHRF)中的应用。NIV通过面罩提供双水平正压通气支持,自1980年代起用于ICU,多项随机试验显示其能有效纠正低通气,已成为高碳酸血症性呼吸衰竭的标准治疗。综述更新证据并描述主要适应证及最可能获益的患者群体。
要点
- NIV是急性高碳酸血症性呼吸衰竭的标准治疗。
- 双水平正压NIV通过面罩提供通气支持,可纠正低通气。
- 综述旨在明确NIV主要适应证及最获益患者群体。
核心结论
- NIV是急性高碳酸血症性呼吸衰竭的有价值治疗,已成为标准治疗。
研究设计与样本
- 综述类文章,检索范围未在摘要中报告。
主要发现
- 自1980年代起NIV用于ICU,初期为个案报道和较大系列,后开展多项随机试验。
- 随机试验数据显示NIV是急性高碳酸血症性呼吸衰竭的有效治疗。
临床怎么用
- 综述提供AHRF中NIV主要适应证的实用描述,并识别最可能从NIV获益的高碳酸血症性呼吸衰竭患者群体。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Non-invasive ventilation (NIV) with bilevel positive airway pressure is a non-invasive technique, which refers to the provision of ventilatory support through the patient's upper airway using a mask or similar device. This technique is successful in correcting hypoventilation. It has become widely accepted as the standard treatment for patients with hypercapnic respiratory failure (HRF). Since the 1980s, NIV has been used in intensive care units and, after initial anecdotal reports and larger series, a number of randomized trials have been conducted. Data from these trials have shown that NIV is a valuable treatment for HRF. This review aims to explore the principal areas in which NIV can be useful, focusing particularly on patients with acute HRF (AHRF). We will update the evidence base with the goal of supporting clinical practice. We provide a practical description of the main indications for NIV in AHRF and identify the group of patients with hypercapnic failure who will benefit most from the application of NIV.
引用
- Comellini V, Pacilli AMG, Nava S, et al. Benefits of non-invasive ventilation in acute hypercapnic respiratory failure. Respirology. 2019. PMID: 30636373. doi:10.1111/resp.13469
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。